FDA Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Condi

Annals of Internal Medicine (ACP) published a clinical update in Research Highlights on 03 Feb 2026. The item focuses on The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions. Review the original article for the full source wording and details.